Perrigo Company plc (PRGO)
USD 25.44
(-3.67%)
USD 25.44
(-3.67%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.04 Billion USD | -2.17% |
| 2022 | 6.17 Billion USD | 17.09% |
| 2021 | 5.27 Billion USD | -9.59% |
| 2020 | 5.83 Billion USD | 6.11% |
| 2019 | 5.49 Billion USD | 3.42% |
| 2018 | 5.31 Billion USD | -2.62% |
| 2017 | 5.45 Billion USD | -31.02% |
| 2016 | 7.91 Billion USD | -12.64% |
| 2015 | 9.05 Billion USD | 74.64% |
| 2014 | 5.18 Billion USD | 71.84% |
| 2013 | 3.01 Billion USD | 39.0% |
| 2012 | 2.17 Billion USD | 30.95% |
| 2011 | 1.65 Billion USD | -17.26% |
| 2010 | 2 Billion USD | 24.14% |
| 2009 | 1.61 Billion USD | -1.64% |
| 2008 | 1.64 Billion USD | 40.21% |
| 2007 | 1.17 Billion USD | 5.48% |
| 2006 | 1.1 Billion USD | -0.38% |
| 2005 | 1.11 Billion USD | 399.92% |
| 2004 | 222.86 Million USD | 13.97% |
| 2003 | 195.54 Million USD | 10.08% |
| 2002 | 177.64 Million USD | -6.52% |
| 2001 | 190.03 Million USD | 42.48% |
| 2000 | 133.38 Million USD | -52.85% |
| 1999 | 282.9 Million USD | 12.98% |
| 1998 | 250.4 Million USD | 75.72% |
| 1997 | 142.5 Million USD | -15.28% |
| 1996 | 168.2 Million USD | -21.8% |
| 1995 | 215.1 Million USD | 19.83% |
| 1994 | 179.5 Million USD | 0.45% |
| 1993 | 178.7 Million USD | 34.16% |
| 1992 | 133.2 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 5.95 Billion USD | -1.46% |
| 2024 Q2 | 5.85 Billion USD | -1.7% |
| 2023 Q1 | 6.12 Billion USD | -0.88% |
| 2023 Q3 | 6.02 Billion USD | -1.57% |
| 2023 Q2 | 6.11 Billion USD | -0.08% |
| 2023 FY | 6.04 Billion USD | -2.17% |
| 2023 Q4 | 6.04 Billion USD | 0.35% |
| 2022 FY | 6.17 Billion USD | 17.09% |
| 2022 Q3 | 6.07 Billion USD | 0.08% |
| 2022 Q2 | 6.06 Billion USD | 14.85% |
| 2022 Q4 | 6.17 Billion USD | 1.65% |
| 2022 Q1 | 5.28 Billion USD | 0.21% |
| 2021 Q1 | 5.76 Billion USD | -1.14% |
| 2021 FY | 5.27 Billion USD | -9.59% |
| 2021 Q2 | 5.71 Billion USD | -0.83% |
| 2021 Q4 | 5.27 Billion USD | -8.01% |
| 2021 Q3 | 5.73 Billion USD | 0.25% |
| 2020 Q1 | 5.61 Billion USD | 2.12% |
| 2020 Q3 | 5.75 Billion USD | -7.43% |
| 2020 Q4 | 5.83 Billion USD | 1.35% |
| 2020 FY | 5.83 Billion USD | 6.11% |
| 2020 Q2 | 6.21 Billion USD | 10.75% |
| 2019 Q4 | 5.49 Billion USD | -0.98% |
| 2019 Q3 | 5.55 Billion USD | -2.64% |
| 2019 Q2 | 5.7 Billion USD | 5.23% |
| 2019 Q1 | 5.41 Billion USD | 1.95% |
| 2019 FY | 5.49 Billion USD | 3.42% |
| 2018 Q1 | 5.43 Billion USD | -0.44% |
| 2018 FY | 5.31 Billion USD | -2.62% |
| 2018 Q4 | 5.31 Billion USD | 0.61% |
| 2018 Q3 | 5.28 Billion USD | -0.85% |
| 2018 Q2 | 5.32 Billion USD | -1.95% |
| 2017 Q2 | 5.71 Billion USD | -27.82% |
| 2017 FY | 5.45 Billion USD | -31.02% |
| 2017 Q4 | 5.45 Billion USD | -5.91% |
| 2017 Q3 | 5.8 Billion USD | 1.57% |
| 2017 Q1 | 7.91 Billion USD | -0.01% |
| 2016 Q2 | 9.63 Billion USD | -0.68% |
| 2016 Q1 | 9.7 Billion USD | 3.66% |
| 2016 Q3 | 8.79 Billion USD | -8.69% |
| 2016 Q4 | 7.91 Billion USD | -10.05% |
| 2016 FY | 7.91 Billion USD | -12.64% |
| 2015 Q1 | 6.59 Billion USD | -2.2% |
| 2015 Q2 | 9.05 Billion USD | 37.3% |
| 2015 Q3 | 8.97 Billion USD | -0.96% |
| 2015 FY | 9.05 Billion USD | 74.64% |
| 2015 Q4 | 9.35 Billion USD | 4.31% |
| 2014 Q4 | 6.74 Billion USD | 33.2% |
| 2014 Q1 | 5.18 Billion USD | -0.53% |
| 2014 FY | 5.18 Billion USD | 71.84% |
| 2014 Q2 | 5.18 Billion USD | 0.05% |
| 2014 Q3 | 5.06 Billion USD | -2.36% |
| 2013 Q4 | 5.21 Billion USD | 71.5% |
| 2013 FY | 3.01 Billion USD | 39.0% |
| 2013 Q1 | 2.27 Billion USD | 3.87% |
| 2013 Q2 | 3.01 Billion USD | 32.93% |
| 2013 Q3 | 3.03 Billion USD | 0.69% |
| 2012 FY | 2.17 Billion USD | 30.95% |
| 2012 Q4 | 2.18 Billion USD | 1.57% |
| 2012 Q3 | 2.15 Billion USD | -0.89% |
| 2012 Q2 | 2.17 Billion USD | -4.23% |
| 2012 Q1 | 2.26 Billion USD | -1.92% |
| 2011 FY | 1.65 Billion USD | -17.26% |
| 2011 Q2 | 1.65 Billion USD | 2.84% |
| 2011 Q3 | 1.96 Billion USD | 18.78% |
| 2011 Q4 | 2.31 Billion USD | 17.37% |
| 2011 Q1 | 1.61 Billion USD | -0.9% |
| 2010 Q2 | 2 Billion USD | 34.36% |
| 2010 Q1 | 1.49 Billion USD | -5.52% |
| 2010 FY | 2 Billion USD | 24.14% |
| 2010 Q3 | 1.56 Billion USD | -21.81% |
| 2010 Q4 | 1.62 Billion USD | 3.83% |
| 2009 Q4 | 1.57 Billion USD | 3.39% |
| 2009 FY | 1.61 Billion USD | -1.64% |
| 2009 Q1 | 1.53 Billion USD | -4.3% |
| 2009 Q2 | 1.61 Billion USD | 5.44% |
| 2009 Q3 | 1.52 Billion USD | -5.41% |
| 2008 Q4 | 1.59 Billion USD | -0.32% |
| 2008 Q2 | 1.64 Billion USD | 22.78% |
| 2008 Q1 | 1.33 Billion USD | 9.31% |
| 2008 Q3 | 1.6 Billion USD | -2.21% |
| 2008 FY | 1.64 Billion USD | 40.21% |
| 2007 Q3 | 1.17 Billion USD | 0.4% |
| 2007 Q4 | 1.22 Billion USD | 4.04% |
| 2007 FY | 1.17 Billion USD | 5.48% |
| 2007 Q1 | 1.18 Billion USD | 2.02% |
| 2007 Q2 | 1.17 Billion USD | -1.23% |
| 2006 Q3 | 1.15 Billion USD | 3.98% |
| 2006 Q4 | 1.16 Billion USD | 0.67% |
| 2006 Q1 | 1.04 Billion USD | -2.96% |
| 2006 FY | 1.1 Billion USD | -0.38% |
| 2006 Q2 | 1.1 Billion USD | 6.06% |
| 2005 Q1 | 1.12 Billion USD | 430.81% |
| 2005 Q4 | 1.07 Billion USD | -1.82% |
| 2005 FY | 1.11 Billion USD | 399.92% |
| 2005 Q2 | 1.11 Billion USD | -0.72% |
| 2005 Q3 | 1.09 Billion USD | -1.41% |
| 2004 Q4 | 211.41 Million USD | 2.53% |
| 2004 Q2 | 222.86 Million USD | 1.41% |
| 2004 Q1 | 219.77 Million USD | 7.15% |
| 2004 Q3 | 206.2 Million USD | -7.47% |
| 2004 FY | 222.86 Million USD | 13.97% |
| 2003 Q4 | 205.1 Million USD | 9.72% |
| 2003 FY | 195.54 Million USD | 10.08% |
| 2003 Q3 | 186.93 Million USD | -4.41% |
| 2003 Q1 | 190.39 Million USD | 4.75% |
| 2003 Q2 | 195.54 Million USD | 2.71% |
| 2002 Q4 | 181.76 Million USD | -5.44% |
| 2002 Q3 | 192.21 Million USD | 8.2% |
| 2002 Q2 | 177.64 Million USD | 11.84% |
| 2002 Q1 | 158.83 Million USD | -2.95% |
| 2002 FY | 177.64 Million USD | -6.52% |
| 2001 Q1 | 168.4 Million USD | 7.08% |
| 2001 Q3 | 204.53 Million USD | 7.63% |
| 2001 Q2 | 190.03 Million USD | 12.84% |
| 2001 Q4 | 163.66 Million USD | -19.98% |
| 2001 FY | 190.03 Million USD | 42.48% |
| 2000 Q1 | 146.18 Million USD | -35.58% |
| 2000 Q2 | 133.38 Million USD | -8.75% |
| 2000 FY | 133.38 Million USD | -52.85% |
| 2000 Q3 | 157.97 Million USD | 18.44% |
| 2000 Q4 | 157.26 Million USD | -0.45% |
| 1999 Q2 | 282.9 Million USD | -19.47% |
| 1999 Q4 | 226.9 Million USD | -14.73% |
| 1999 FY | 282.9 Million USD | 12.98% |
| 1999 Q1 | 351.3 Million USD | -8.73% |
| 1999 Q3 | 266.1 Million USD | -5.94% |
| 1998 Q4 | 384.9 Million USD | 21.88% |
| 1998 Q1 | 216.7 Million USD | -0.18% |
| 1998 Q2 | 250.4 Million USD | 15.55% |
| 1998 FY | 250.4 Million USD | 75.72% |
| 1998 Q3 | 315.8 Million USD | 26.12% |
| 1997 Q1 | 145.5 Million USD | -8.38% |
| 1997 FY | 142.5 Million USD | -15.28% |
| 1997 Q4 | 217.1 Million USD | 15.36% |
| 1997 Q3 | 188.2 Million USD | 32.07% |
| 1997 Q2 | 142.5 Million USD | -2.06% |
| 1996 Q2 | 168.2 Million USD | -11.15% |
| 1996 Q1 | 189.3 Million USD | -17.26% |
| 1996 FY | 168.2 Million USD | -21.8% |
| 1996 Q4 | 158.8 Million USD | -11.68% |
| 1996 Q3 | 179.8 Million USD | 6.9% |
| 1995 Q4 | 228.8 Million USD | -5.18% |
| 1995 Q3 | 241.3 Million USD | 12.18% |
| 1995 Q2 | 215.1 Million USD | -0.32% |
| 1995 Q1 | 215.8 Million USD | 17.09% |
| 1995 FY | 215.1 Million USD | 19.83% |
| 1994 Q1 | 180.7 Million USD | -3.83% |
| 1994 Q2 | 179.5 Million USD | -0.66% |
| 1994 Q4 | 184.3 Million USD | -6.07% |
| 1994 FY | 179.5 Million USD | 0.45% |
| 1994 Q3 | 196.2 Million USD | 9.3% |
| 1993 Q1 | 166.2 Million USD | 6.2% |
| 1993 FY | 178.7 Million USD | 34.16% |
| 1993 Q4 | 187.9 Million USD | -9.27% |
| 1993 Q2 | 178.7 Million USD | 7.52% |
| 1993 Q3 | 207.1 Million USD | 15.89% |
| 1992 Q4 | 156.5 Million USD | 2.49% |
| 1992 FY | 133.2 Million USD | 0.0% |
| 1992 Q1 | 121.7 Million USD | 67.4% |
| 1992 Q3 | 152.7 Million USD | 14.64% |
| 1992 Q2 | 133.2 Million USD | 9.45% |
| 1991 Q4 | 72.7 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 3.45 Billion USD | -74.978% |
| Bausch Health Companies Inc. | 27.43 Billion USD | 77.978% |
| Catalent, Inc. | 6.14 Billion USD | 1.753% |
| Emergent BioSolutions Inc. | 1.18 Billion USD | -409.548% |
| Elanco Animal Health Incorporated | 8.13 Billion USD | 25.775% |
| Teva Pharmaceutical Industries Limited | 35.35 Billion USD | 82.912% |
| Zoetis Inc. | 9.29 Billion USD | 35.006% |